You do not have javascript enabled. Some of the features of the site may not work correctly.

Opportunity details

Use of oral anticoagulants (warfarin, dabigatran, rivaroxaban, apixaban, edoxaban)

Are you affected by atrial fibrillation/ venous thromboembolism/ coronary artery disease?

Link to organisation:

Full description:

There is limited scientific evidence regarding the health outcomes relating to drug-drug interactions of oral anticoagulants. If you are affected by atrial fibrillation/venous thromboembolism/coronary artery disease/ peripheral artery disease, you might receive oral anticoagulants to prevent cardiovascular events.

We would like your help to tell us how important drug interactions mean to you when deciding the treatment options and comment on our abstract of the research proposal.

Date from

2nd November 2018

Date to

3rd December 2018


Electronic Health Records research group in London School of Hygiene and Tropical Medicine

The group is world leading in the use of electronic health records for
public health research, with a major focus on assessing the risks and benefits of medicines.



Stroke or cardiovascular disease


UK wide

Involvement type:

Identifying and prioritising

What support is offered?

Support and training will be offered in line with INVOLVE guidelines





Can the work be done from home?


Suitable for a beginner?


View Contact Details